Obalon Therapeutics, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a OBLN research report →
About the company
Obalon Therapeutics, Inc. operates as a fully integrated medical device enterprise, concentrating its efforts on creating and commercializing innovative solutions for individuals battling obesity. The company's flagship offering is the Obalon Balloon System, specifically engineered to promote weight reduction in obese patients.
- CEO
- Kelly Huang
- IPO
- 2016
- Employees
- 2
- HQ
- Carlsbad, CA, US
Price Chart
- Market Cap
- $5.47M
- P/E
- -1.67
- P/S
- -7.18
- P/B
- 0.44
- EV/EBITDA
- 0.28
- Div Yield
- 0.00%
- Gross Margin
- 58.50%
- Op Margin
- 1265.59%
- Net Margin
- 1539.01%
- ROE
- -232.57%
- ROIC
- -119.55%
- Revenue
- $319.71K · -96.01%
- Net Income
- $-10,477,713 · -46.95%
- EPS
- $0.00 · 100.00%
- Op Income
- $-10,351,627
- FCF YoY
- 100.00%
- 52W High
- $32.31
- 52W Low
- $1.98
- 50D MA
- $9.07
- 200D MA
- $9.08
- Beta
- -1.24
- Avg Volume
- 1.51M
Get TickerSpark's AI analysis on OBLN
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Sep 16, 20 | Stevenson Sharon | other | 27,250 |
| Sep 16, 20 | Stevenson Sharon | other | 27,250 |
| Sep 16, 20 | DITTAMORE RAYMOND V | other | 27,250 |
| Sep 16, 20 | DITTAMORE RAYMOND V | other | 27,250 |
| Jun 23, 20 | Hussainy Nooshin | other | 165,135 |
| Jun 23, 20 | Hussainy Nooshin | other | 52,865 |
| Jun 23, 20 | Rasdal Andrew P | other | 165,135 |
| Jun 23, 20 | Rasdal Andrew P | other | 52,865 |
| Jan 24, 20 | Hussainy Nooshin | other | 88,225 |
| Jan 24, 20 | VandenBerg Amy | other | 88,225 |
Our OBLN coverage
Recent articles, reports, and earnings notes.
No research on OBLN yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate OBLN report →Similar companies
Peers in the same neighborhood.